| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 440.1K | $19.61M | -64,000 | |
| Other | 138.6K | $6.17M | -7,215 | |
| Other | 123.1K | $5.48M | - | |
| CFO | 116.9K | $5.21M | -8,262 | |
| Other | 111.5K | $4.97M | -8,233 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | Dube Eric M57 | Chief Executive Officer | Sell | 10,736 | $19.46 | $208,922.56 | -3.0% | -18.4% | +52.8% | |
| Jan 22, 2025 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 2,437 | $19.46 | $47,424.02 | -3.1% | -18.4% | +52.8% | |
| Jan 22, 2025 | Heerma Peter53 | Chief Commercial Officer | Sell | 1,584 | $18.94 | $30,002.23 | -1.5% | -18.4% | +52.8% | |
| Jan 22, 2025 | Cline Christopher R.50 | Chief Financial Officer | Sell | 865 | $18.94 | $16,383.88 | -1.2% | -18.4% | +52.8% | |
| Jan 22, 2025 | Calvin Sandra60 | SVP, Chief Accounting Officer | Sell | 925 | $18.94 | $17,520.24 | -1.7% | -18.4% | +52.8% | |
| Jan 6, 2025 | Inrig Jula45 | Chief Medical Officer | Sell | 2,506 | $19.04 | $47,715.00 | -2.1% | -18.9% | +91.3% | |
| Dec 26, 2024 | Calvin Sandra60 | SVP, Chief Accounting Officer | Sale+OE | 15,000 | $17.22 | $258,277.50 | -21.5% | +16.9% | +122.9% | |
| Nov 25, 2024 | Calvin Sandra60 | SVP, Chief Accounting Officer | Sale+OE | 12,090 | $18.30 | $221,257.88 | -18.0% | +16.7% | +98.1% | |
| Oct 4, 2024 | Lyons Gary A54 | Director | Sale+OE | 40,000 | $14.73 | $589,100.78 | -24.9% | +24.6% | +61.8% | |
| Sep 30, 2024 | Meckler Jeffrey A45 | Director | Sale+OE | 40,000 | $14.06 | $562,324.00 | -33.1% | +23.8% | +70.8% |